🇺🇸 FDA
Patent

US 7416724

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

granted A61PA61P35/00A61P9/00

Quick answer

US patent 7416724 (Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P35/00, A61P9/00, A61P9/10